Axela Angle to Buy Axela, Plans to Raise £12.2M in Share Placement About £3.7 million ($4.9 million) of proceeds from the placement would go toward the acquisition, while remaining funds will support assay development validation, and working capital. University of Pittsburgh, Axela Test for Shaken Baby Syndrome Shows 90 Percent Sensitivity in Study The blood-based test is based on three serum biomarkers —matrix metallopeptidase-9, neuron-specific enolase, and vascular cellular adhesion molecule-1. Scienion, Axela Ink Joint Array Development Agreement The firms will collaborate on creating and co-marketing array technologies for research and clinical diagnostics. Axela, PAML Collaborate on Immune Status Multiplex Assays The partners will work together to develop serological assays measuring antibodies to determine patient immunity to diseases for which vaccines exist. Axela, Hutman Provide Update on Multiplex Pathogen Detection System Development Premium Axela and Hutman Diagnostics last week announced progress in the co-development of a multiplex pathogen detection system. Sep 24, 2013 Axela Partners with Hutman Dx to Develop Automated Multiplex Pathogen Detection System Premium Jul 9, 2013 Axela, Thermal Gradient Ink Deal for Technology Integration Feb 1, 2013 Axela Hires Investment Bank to Explore Strategic Opportunities, Including Potential Sale Aug 21, 2012 Axela Partners with OvaGene to Commercialize Ovarian Cancer PGx Test Premium Jul 12, 2012 Two Hospitals Collaborate to Assess Axela Breast Cancer Assay May 17, 2012 Isogen to Distribute Axela Platforms Mar 2, 2012 In Brief This Week: PerkinElmer; Thermo Fisher Scientific; Axela; BioStorage Technologies; Berg Diagnostics; Modern Mobility Aids, Lumigene Feb 16, 2012 Axela, Cronus Ink Distribution Deal for UK, Ireland Feb 3, 2012 New Products: Axela's dotLab mX System Premium Dec 15, 2011 Sony DADC, Axela Partner on Smart Consumables Aug 2, 2011 Axela Taps Digilab to Market Array Analysis Systems to US Customers Premium Aug 2, 2011 Digilab Marketing Axela Instruments Jul 27, 2010 Axela Acquires Xceed Molecular to Bolster Biomarker Discovery Business Premium Jul 26, 2010 Axela Acquires Xceed Molecular Mar 19, 2009 Industry Briefs: Mar 19, 2009 Premium Breaking News US Supreme Court Declines to Hear CareDx Organ Transplant Patent Infringement Case GenomeWeb Top 40 Down 10 Percent in September, Outpacing Decline in Broader Market Natera Submits Signatera Bladder Cancer PMA Module to FDA FDA Grants Emergency Use Authorizations for POC COVID Tests from Tangen Biosciences, SD Biosensor Top Five Articles on GenomeWeb Last Week: FDA Proposal for LDT Oversight, Adela $48M Financing, More The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.